Abstract
The purpose of this review is to put into a useful clinical context the changing over time of basic ovarianpituitary-hypothalamic relationships during perimenopause. “Perimenopause” means changes in ovarian hormones, feedback relationships, and clinical experiences beginning in women ages 35–50 with regular flow and ending 1 yr after the final menstrual flow. A key observation must be explained—estradiol levels are increased in perimenopause. Inhibin B levels are lower and activin may be higher in midlife, menstruating women. These changes probably cause higher follicular phase FSH levels—“endogenous ovarian hyperstimulation” results. The positive estradiol feedback on LH is also disturbed—midcycle LH peaks and midluteal slow-frequency, high-amplitude LH pulses are less frequent. In addition to higher levels, estradiol receptors may increase in tissues of symptomatic women. Despite hyperstimulation of follicles, progesterone levels and luteal phase lengths are paradoxically decreased —reasons probably include LH peak disruptions and estrogen-stimulated greater corticotrophin-mediated reproductive suppression. In summary, disturbed feedback relationships causing higher and unpredictable estrogen and lower progesterone levels occur throughout perimenopause, especially during regular cycles. Prospective, population-based research is needed to systematically relate these feedback hormonal changes to clinical characteristics and to allow a diagnosis of perimenopause in regularly cycling midlife women.
Similar content being viewed by others
References
Prior, J. C. (1998). Endocr. Rev. 19, 397–428.
Hale, G. E., Hitchcock, C. L., Williams, L. A., Vigna, Y. M., and Prior, J. C. (2003). Climacteric 6, 128–139.
Prior, J. C. (2002). In: Endocrine facets of ageing. Chadwick, D. J. and Goode, J. A. (eds.). John Wiley and Sons Ltd: Chichester, UK, pp. 172–186.
Treloar, A. E., Boyton, R. E., Behn, B. G., and Brown, B. W. (1967). Int. J. Fertil. 12, 77–126.
Mansfield, P. K., Carey, M., Anderson, A., Barsom, S. H., and Koch, P. B. (2004). Womens Health Issues 14, 220–226.
Wallace, R. B., Sherman, B. M., Bean, J. A., Treloar, A. E., and Schlabaugh, L. (1979). Am. J. Obstet. Gynecol. 135, 1021–1024.
Burger, H. G., Dudley, E. C., Hopper, J. L., et al. (1995). J. Clin. Endocrinol. Metab. 80, 3537–3545.
Prior, J. C., Barr, S. I., and Vigna, Y. M. (1996). J. Clin. Endocrinol. Metab. 81, 3127–3128.
Santoro, N., Rosenberg, J., Adel, T., and Skurnick, J. H. (1996). J. Clin. Endocrinol. Metab. 81, 41495–41501.
Landgren, B. M., Collins, A., Csemiczky, G., Burger, H. G., Baksheev, L., and Robertson, D. M. (2004). J. Clin. Endocrinol. Metab. 89, 2763–2769.
Abraham, G. E., Chakmakjian, Z. H., Buster, J. E., and Marshall, J. R. (1974). Obstet. Gynecol. 43, 676–684.
Vollman, R. F. (1977). In: Major problems in obstetrics and gynecology, Vol 7. Friedman, E. A. (ed.). W.B. Saunders Company: Toronto, pp. 11–193.
Soules, M. R., Sherman, S., Parrott, E., et al. (2001). Fertil. Steril. 76, 874–878.
Garai, J., Vilagi, S., Repasy, I., Koppan, M., and Bodis, J. (2004). Hum. Reprod. 19, 1666–1667.
Dennerstein, L., Dudley, E. C., Hopper, J. L., Guthrie, J. R., and Burger, H. G. (2000). Obstet. Gynecol. 96, 351–358.
Seifer, D. B., Gardiner, A. C., Lambert-Messerlian, G., and Schneyer, A. L. (1996). J. Clin. Endocrinol. Metab. 81, 736–739.
Welt, C. K., Smith, Z. A., Pauler, D. K., and Hall, J. E. (2001). J. Clin. Endocrinol. Metab. 86, 2531–2537.
Burger, H. G. (1993). J. Clin. Endocrinol. Metab. 76, 1391–1396.
Groome, N. P., Illingworth, P. J., O’Brien, M., et al. (1994). Clin. Endocr. 40, 717–723.
MacNaughton, J., Banah, M., McCloud, P. I., Hee, J. P., and Burger, H. G. (1992). Clin. Endocr. 36, 339–345.
Klein, N. A., Illingworth, P. J., Groome, N. P., McNeilly, A. S., Battaglia, A. S., and Soules, M. R. (1996). J. Clin. Endocrinol. Metab. 81, 2742–2745.
Findlay, J. K., Xiao, S., and Shukovski, L. (1990). Reprod. Fertil. Dev. 2, 205–218.
Welt, C. K., McNicholl, D. J., Taylor, A. E., and Hall, J. E. (1999). J. Clin. Endocrinol. Metab. 84, 105–111.
Burger, H. G., Dudley, E. C., Hopper, J. L., et al. (1999). J. Clin. Endocrinol. Metab. 84, 4025–4030.
Reame, N. E., Wyman, T. L., Phillips, D. J., de Kretser, D. M., and Padmanabhan, V. (1998). J. Clin. Endocrinol. Metab. 83, 3302–3307.
Djerassi, A., Coutifaris, C., West, V. A., et al. (1995). J. Clin. Endocrinol. Metab. 80, 591–594.
Reame, N. E., Kelch, R. P., Bietins, I. Z., Yu, M.-Y., Zawacki, C. M., and Padmanabhan, V. (1996). J. Clin. Endocrinol. Metab. 81, 1512–1518.
Miro, F., Parker, S. W., Aspinall, L. J., Coley, J., Perry, P. W., and Ellis, J. E. (2004). J. Clin. Endocrinol. Metab. 89, 3270–3275.
Park, S. J., Goldsmith, L. T., and Weiss, G. (2002). Exp. Biol. Med. (Maywood) 227, 455–464.
Ballinger, C. B. (1975). Br. Med. J. 3, 344–346.
Moen, M. H., Kahn, H., Bjerve, K. S., and Halvorsen, T. B. (2004). Maturitas 47, 151–155.
Shideler, S. E., DeVane, G. W., Kalra, P. S., Bernirschke, K., and Lasley, B. L. (1989). Maturitas 11, 331–339.
Kaufert, P. A. (1980). Maturitas 2, 191–205.
Johannes, C. B., Crawford, S. L., Longcope, C., and McKinlay, S. M. (1996). Clin. Consult. Obstet. Gynecol. 8, 9–20.
Kaufert, P. A., Gilbert, P., and Tate, R. (1987). Maturitas 9, 217–226.
Gleeson, N., Jordan, M., Sheppard, B., and Bonnar, J. (1993). Eur. J. Obstet. Gynecol. Reprod. Biol. 48, 207–214.
Weel, A. E., Uitterlinden, A. G., Westendorp, I. C., et al. (1999). J. Clin. Endocrinol. Metab. 84, 3146–3150.
Brambilla, D. J., McKinlay, S. M., Johannes, C. B., et al. (1994). Am. J. Epidemiol. 140, 1091–1095.
Prior, J. C. (2002). In: Conn’s current therapy. Rabel, R. E. and Bope, E. T. (eds.). W.B. Saunders Company: New York, pp. 1078–1080.
Kirschbaum, C., Schommer, N., Federenko, I., et al. (1996). J. Clin. Endocrinol. Metab. 81, 3639–3643.
Gambacciani, M., Yen, S. S. C., and Rasmussen, D. D. (1986). Neuroendocr. 43, 533–536.
Burger, H. G., Dudley, E. C., Robertson, D. M., and Dennerstein, L. (2002). Recent Prog. Horm. Res. 57, 257–275.
Metcalf, M. G. (1988). N.Z. Med. J. 101, 103–106.
Metcalf, M. G. (1979). J. Biosoc. Sci. 11, 39–48.
Metcalf, M. G. and MacKenzie, J. A. (1985). J. Endocrinol. 104, 137–141.
Gilfillan, C. P., Robertson, D. M., Burger, H. G., Leoni, M. A., Hurley, V. A., and Martin, N. G. (1996). J. Clin. Endocrinol. Metab. 81, 1557–1562.
Faddy, M. J., Gosden, R. G., Gougeon, A., Richardson, S. J., and Nelson, J. F. (1992). Hum. Reprod. 7, 1342–1346.
Wilbur, J., Miller, A. M., Montgomery, A., and Chandler, P. (1998). Menopause 5, 43–51.
Fitzgerald, C. T., Seif, M. W., Killick, S. R., and Bennett, D. A. (1994). Br. J. Obstet. Gynaecol. 101, 229–233.
Morse, C. A., Dudley, E., Guthrie, J., and Dennerstein, L. (1989). J. Psychosom. Obstet. Gynecol. 19, 182–191.
Fraser, I. S. (1990). Aust. N.Z. J. Obstet. Gynaecol. 30, 353–356.
Schiff, I., Tulchinsky, D., Cramer, D., and Ryan, K. J. (1980). J. Am. Med. Assoc. 244, 1443–1445.
Friess, E., Tagaya, H., Trachsel, L., Holsboer, F., and Rupprecht, R. (1997). Am. J. Physiol. 272, E885-E891.
Dennerstein, L., Spencer-Gardner, C., Gotts, G., Brown, J. B., and Smith, M. A. (1985). Br. Med. J. 290, 1617–1621.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Prior, J.C. Ovarian aging and the perimenopausal transition. Endocr 26, 297–300 (2005). https://doi.org/10.1385/ENDO:26:3:297
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:26:3:297